Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 118 Neoplasms 110 Lung Neoplasms 65 Colorectal Neoplasms 52 Prostatic Neoplasms 46 Carcinoma, Non-Small-Cell Lung 46 Pancreatic Neoplasms 34 Melanoma 33 Ovarian Neoplasms 29 Neoplastic Cells, Circulating 29 Head and Neck Neoplasms 27 Uterine Cervical Neoplasms 23 Multiple Myeloma 20 Glioma 20 Colonic Neoplasms 20 Sarcoma 19 Carcinoma, Hepatocellular 19 Leukemia, Myeloid, Acute 18 Neoplasm Metastasis 17 Lymphoma 15 Glioblastoma 15 Esophageal Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 14 Hematologic Neoplasms 14 Leukemia 13 Endometrial Neoplasms 13 Myelodysplastic Syndromes 11 Kidney Neoplasms 11 Gastrointestinal Neoplasms 11 Carcinoma, Renal Cell 11

Interventions

Doxorubicin 18 Ifosfamide 13 Radiotherapy 8 Paclitaxel 7 pazopanib 6 pembrolizumab 4 Gemcitabine 4 Filgrastim 4 Chemotherapy, Adjuvant 4 Bevacizumab 4 spartalizumab 3 durvalumab 3 Sorafenib 3 Propranolol 3 Nivolumab 3 Ipilimumab 3 Imatinib Mesylate 3 Etoposide 3 Epirubicin 3 Docetaxel 3 Carboplatin 3 trebananib 2 regorafenib 2 cixutumumab 2 cemiplimab 2 carotuximab 2 brostallicin 2 belinostat 2 balstilimab 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemangiosarcoma × Blood Specimen Collection × Clear all

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡